URB597
Encyclopedia : U : UR : URB : URB597
In pre-clinical laboratory tests researchers found URB597 increased the production of endocannabinoids by blocking their degradation, resulting in measurable antidepressant effects.
URB597 is also known as KDS-4103. KDS-4103 is being developed by Kadmus Pharmaceuticals, Inc. for clinical trials in humans.
External links
- [Kadmus Pharmaceuticals official website]
- [Modulation of anxiety through blockade of anandamide hydrolysis] in ''Nature
- [New drug acts as marijuana in the brain] at cannabis.net
From Wikipedia, the Free Encyclopedia. Original article here. Support Wikipedia by contributing or donating.
All text is available under the terms of the GNU Free Documentation License See Wikipedia Copyrights for details.